Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

NCT00129259 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

NIH

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

BIOLOGICAL: Anti-CD3 mAb
OTHER: Diabetes Standard of Care Treatment
DIETARY_SUPPLEMENT: Iron supplementation

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]